Mediwelcome Healthcare Management & Technology Inc. (HKG:2159)
Hong Kong · Delayed Price · Currency is HKD 1.440
-0.010 (-0.69%)
At close: Jan 23, 2026
HKG:2159 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 307.94 | 321.56 | 331.31 | 323.37 | 708.36 | 432.29 | Upgrade | |
Revenue Growth (YoY) | -5.27% | -2.94% | 2.45% | -54.35% | 63.86% | 1.20% | Upgrade |
Cost of Revenue | 255.84 | 270.55 | 301.41 | 290.82 | 614.76 | 335.98 | Upgrade |
Gross Profit | 52.1 | 51 | 29.9 | 32.55 | 93.6 | 96.31 | Upgrade |
Selling, General & Admin | 50.88 | 60.59 | 73.35 | 75.56 | 75.84 | 52.33 | Upgrade |
Research & Development | 12.93 | 18.68 | 32.69 | 50.61 | 18.7 | 14.01 | Upgrade |
Operating Expenses | 69.52 | 87.21 | 111.81 | 129.59 | 86.92 | 67.37 | Upgrade |
Operating Income | -17.42 | -36.21 | -81.92 | -97.04 | 6.67 | 28.94 | Upgrade |
Interest Expense | -1.31 | -1.09 | -1.3 | -1.25 | -1.26 | -0.9 | Upgrade |
Interest & Investment Income | 0.2 | 0.26 | 0.42 | 0.62 | 0.79 | 0.3 | Upgrade |
Currency Exchange Gain (Loss) | -0.03 | 0.73 | 0.48 | 2.79 | -0.77 | -0.01 | Upgrade |
Other Non Operating Income (Expenses) | 0.74 | 0.19 | 3.17 | 2.47 | -0.86 | -6.92 | Upgrade |
EBT Excluding Unusual Items | -17.81 | -36.11 | -79.16 | -92.41 | 4.57 | 21.42 | Upgrade |
Gain (Loss) on Sale of Investments | 0.43 | 0.46 | 2.19 | 1.27 | 1.03 | 0.42 | Upgrade |
Gain (Loss) on Sale of Assets | -0.06 | -0.06 | -0.05 | - | -0.02 | -0.03 | Upgrade |
Asset Writedown | -11.68 | -11.68 | -20.45 | - | - | - | Upgrade |
Other Unusual Items | 2.21 | 2.21 | 1.09 | 0.1 | - | 0.47 | Upgrade |
Pretax Income | -26.91 | -45.17 | -96.38 | -91.04 | 5.59 | 22.28 | Upgrade |
Income Tax Expense | 1.2 | 1.78 | -0.29 | 2.71 | 0.39 | 0.3 | Upgrade |
Earnings From Continuing Operations | -28.1 | -46.95 | -96.09 | -93.74 | 5.2 | 21.98 | Upgrade |
Minority Interest in Earnings | -1.05 | 1.7 | 2 | 4.54 | -0.56 | -0.94 | Upgrade |
Net Income | -29.16 | -45.25 | -94.1 | -89.2 | 4.65 | 21.04 | Upgrade |
Net Income to Common | -29.16 | -45.25 | -94.1 | -89.2 | 4.65 | 21.04 | Upgrade |
Net Income Growth | - | - | - | - | -77.92% | 0.91% | Upgrade |
Shares Outstanding (Basic) | 191 | 191 | 191 | 186 | 181 | 150 | Upgrade |
Shares Outstanding (Diluted) | 191 | 191 | 191 | 186 | 182 | 150 | Upgrade |
Shares Change (YoY) | 0.01% | - | 3.03% | 1.98% | 21.48% | - | Upgrade |
EPS (Basic) | -0.15 | -0.24 | -0.49 | -0.48 | 0.03 | 0.14 | Upgrade |
EPS (Diluted) | -0.15 | -0.24 | -0.49 | -0.48 | 0.03 | 0.14 | Upgrade |
EPS Growth | - | - | - | - | -81.82% | 0.91% | Upgrade |
Free Cash Flow | 10.32 | -15.02 | -76.98 | -19.87 | -2.06 | 26.1 | Upgrade |
Free Cash Flow Per Share | 0.05 | -0.08 | -0.40 | -0.11 | -0.01 | 0.17 | Upgrade |
Gross Margin | 16.92% | 15.86% | 9.02% | 10.07% | 13.21% | 22.28% | Upgrade |
Operating Margin | -5.66% | -11.26% | -24.73% | -30.01% | 0.94% | 6.69% | Upgrade |
Profit Margin | -9.47% | -14.07% | -28.40% | -27.58% | 0.66% | 4.87% | Upgrade |
Free Cash Flow Margin | 3.35% | -4.67% | -23.24% | -6.14% | -0.29% | 6.04% | Upgrade |
EBITDA | -15.93 | -34.6 | -79.32 | -93.79 | 11.32 | 34.9 | Upgrade |
EBITDA Margin | -5.17% | -10.76% | -23.94% | -29.00% | 1.60% | 8.07% | Upgrade |
D&A For EBITDA | 1.49 | 1.61 | 2.6 | 3.25 | 4.65 | 5.96 | Upgrade |
EBIT | -17.42 | -36.21 | -81.92 | -97.04 | 6.67 | 28.94 | Upgrade |
EBIT Margin | -5.66% | -11.26% | -24.73% | -30.01% | 0.94% | 6.69% | Upgrade |
Effective Tax Rate | - | - | - | - | 6.91% | 1.35% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.